Literature DB >> 12095693

Transcriptional regulation of the mouse fatty acid amide hydrolase gene.

N S Waleh1, B F Cravatt, A Apte-Deshpande, A Terao, T S Kilduff.   

Abstract

Fatty acid amide hydrolase (FAAH) is a membrane-bound enzyme that inactivates a family of fatty acid amide molecules which are implicated in physiological processes such as pain and sleep. We cloned a 1.9 kb fragment of the 5'-untranslated region of the mouse FAAH gene into the pGL3 basic luciferase reporter vector and showed that this sequence has promoter activity in vitro. By primer extension analysis, we have determined the transcription start site to be 200 bases upstream of the ATG initiation codon and found that a TATA motif was absent. A number of putative response elements, including those for estrogen and glucocorticoids, were identified in this sequence. We have demonstrated that the estrogen and glucocorticoid receptors down-regulate transcriptional activity independent of their ligand. These data should help in understanding the mechanisms of FAAH gene transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095693     DOI: 10.1016/s0378-1119(02)00598-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  29 in total

1.  Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Authors:  Antonia Serrano; Patricia Rivera; Francisco J Pavon; Juan Decara; Juan Suárez; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Alcohol Clin Exp Res       Date:  2011-12-05       Impact factor: 3.455

2.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.

Authors:  N P Bowles; M N Hill; S M Bhagat; I N Karatsoreos; C J Hillard; B S McEwen
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

Review 3.  The endocannabinoid system: a general view and latest additions.

Authors:  Luciano De Petrocellis; Maria Grazia Cascio; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

4.  Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat.

Authors:  Shuangsong Hong; Gen Zheng; Xiaoyin Wu; Natasha T Snider; Chung Owyang; John W Wiley
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 5.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

6.  Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.

Authors:  J M Ho; N S Smith; S A Adams; H B Bradshaw; G E Demas
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

7.  The faah gene is the first direct target of estrogen in the testis: role of histone demethylase LSD1.

Authors:  Paola Grimaldi; Mariangela Pucci; Sara Di Siena; Daniele Di Giacomo; Valentina Pirazzi; Raffaele Geremia; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2012-07-17       Impact factor: 9.261

8.  COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation.

Authors:  A Straiker; J Wager-Miller; S S Hu; J L Blankman; B F Cravatt; K Mackie
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 9.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

Review 10.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.